{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:22:28Z","timestamp":1778718148388,"version":"3.51.4"},"reference-count":173,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["1DP2HL132390-01"],"award-info":[{"award-number":["1DP2HL132390-01"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["14SDG20160041"],"award-info":[{"award-number":["14SDG20160041"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Regen. Eng. Transl. Med."],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s40883-016-0012-9","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T18:37:43Z","timestamp":1457030263000},"page":"37-50","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Engineering Nanomaterials to Address Cell-Mediated Inflammation in Atherosclerosis"],"prefix":"10.1007","volume":"2","author":[{"given":"Sean","family":"Allen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8945-2892","authenticated-orcid":false,"given":"Evan","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,3]]},"reference":[{"key":"12_CR1","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1161\/CIR.0b013e31820a55f5","volume":"123","author":"PA Heidenreich","year":"2011","unstructured":"Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123:933\u201344.","journal-title":"Circulation"},{"key":"12_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.7326\/0003-4819-48-1-83","volume":"48","author":"A Keys","year":"1958","unstructured":"Keys A, Kimura N, Kusukawa A, Bronte-Stewart B, Larsen N, Keys MH. Lessons from serum cholesterol studies in Japan, Hawaii and Los Angeles. Ann Intern Med. 1958;48:83\u201394.","journal-title":"Ann Intern Med"},{"key":"12_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0140-6736(80)90620-0","volume":"1","author":"A Keys","year":"1980","unstructured":"Keys A. Wine, garlic, and CHD in seven countries. Lancet. 1980;1:145\u20136.","journal-title":"Lancet"},{"key":"12_CR4","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1056\/NEJMoa054013","volume":"354","author":"JC Cohen","year":"2006","unstructured":"Cohen JC, Boerwinkle E, Mosley Jr TH, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med. 2006;354:1264\u201372.","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"12_CR5","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1194\/jlr.R800091-JLR200","volume":"50","author":"JD Horton","year":"2009","unstructured":"Horton JD, Cohen JC, Hobbs HH. PCSK9: a convertase that coordinates LDL catabolism. J Lipid Res. 2009;50(Suppl):S172\u20137.","journal-title":"J Lipid Res"},{"key":"12_CR6","doi-asserted-by":"crossref","unstructured":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-9.","DOI":"10.1016\/S0140-6736(94)90566-5"},{"key":"12_CR7","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1146\/annurev.bi.46.070177.004341","volume":"46","author":"JL Goldstein","year":"1977","unstructured":"Goldstein JL, Brown MS. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem. 1977;46:897\u2013930.","journal-title":"Annu Rev Biochem"},{"key":"12_CR8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/CIRCULATIONAHA.115.011646","volume":"133","author":"LD Colantonio","year":"2016","unstructured":"Colantonio LD, Bittner V, Reynolds K, Levitan EB, Rosenson RS, Banach M, et al. Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies. Circulation. 2016;133:256\u201364.","journal-title":"Circulation"},{"key":"12_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1749-6632.1997.tb52004.x","volume":"811","author":"JP Strong","year":"1997","unstructured":"Strong JP, Malcom GT, Oalmann MC, Wissler RW. The PDAY Study: natural history, risk factors, and pathobiology. Pathobiological Determinants of Atherosclerosis in Youth. Ann N Y Acad Sci. 1997;811:226\u201335. discussion 35-7.","journal-title":"Ann N Y Acad Sci"},{"key":"12_CR10","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685\u201395.","journal-title":"N Engl J Med"},{"key":"12_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nrd3444","volume":"10","author":"IF Charo","year":"2011","unstructured":"Charo IF, Taub R. Anti-inflammatory therapeutics for the treatment of atherosclerosis. Nat Rev Drug Discov. 2011;10:365\u201376.","journal-title":"Nat Rev Drug Discov"},{"key":"12_CR12","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.112.122556","volume":"126","author":"PM Ridker","year":"2012","unstructured":"Ridker PM, Howard CP, Walter V, Everett B, Libby P, Hensen J, et al. Effects of interleukin-1beta inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial. Circulation. 2012;126:2739\u201348.","journal-title":"Circulation"},{"key":"12_CR13","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1146\/annurev.immunol.22.012703.104538","volume":"23","author":"ES Trombetta","year":"2005","unstructured":"Trombetta ES, Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol. 2005;23:975\u20131028.","journal-title":"Annu Rev Immunol"},{"key":"12_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","volume":"14","author":"A Albanese","year":"2012","unstructured":"Albanese A, Tang PS, Chan WC. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng. 2012;14:1\u201316.","journal-title":"Annu Rev Biomed Eng"},{"key":"12_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","volume":"307","author":"DE Owens 3rd","year":"2006","unstructured":"Owens 3rd DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 2006;307:93\u2013102.","journal-title":"Int J Pharm"},{"key":"12_CR16","first-page":"845","volume":"46","author":"R van Furth","year":"1972","unstructured":"van Furth R, Cohn ZA, Hirsch JG, Humphrey JH, Spector WG, Langevoort HL. The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull World Health Organ. 1972;46:845\u201352.","journal-title":"Bull World Health Organ"},{"key":"12_CR17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nature08604","volume":"462","author":"JA Hubbell","year":"2009","unstructured":"Hubbell JA, Thomas SN, Swartz MA. Materials engineering for immunomodulation. Nature. 2009;462:449\u201360.","journal-title":"Nature"},{"key":"12_CR18","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1002\/adma.201200446","volume":"24","author":"JJ Moon","year":"2012","unstructured":"Moon JJ, Huang B, Irvine DJ. Engineering nano- and microparticles to tune immunity. Adv Mater. 2012;24:3724\u201346.","journal-title":"Adv Mater"},{"key":"12_CR19","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0022-2275(20)39928-4","volume":"35","author":"R Van Antwerpen","year":"1994","unstructured":"Van Antwerpen R, Gilkey JC. Cryo-electron microscopy reveals human low density lipoprotein substructure. J Lipid Res. 1994;35:2223\u201331.","journal-title":"J Lipid Res"},{"key":"12_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.it.2015.05.007","volume":"36","author":"DR Getts","year":"2015","unstructured":"Getts DR, Shea LD, Miller SD, King NJ. Harnessing nanoparticles for immune modulation. Trends Immunol. 2015;36:419\u201327.","journal-title":"Trends Immunol"},{"key":"12_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12948-015-0020-1","volume":"13","author":"C Petrarca","year":"2015","unstructured":"Petrarca C, Clemente E, Amato V, Pedata P, Sabbioni E, Bernardini G, et al. Engineered metal based nanoparticles and innate immunity. Clin Mol Allergy: CMA. 2015;13:13.","journal-title":"Clin Mol Allergy: CMA"},{"key":"12_CR22","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nri3488","volume":"13","author":"DM Smith","year":"2013","unstructured":"Smith DM, Simon JK, Baker Jr JR. Applications of nanotechnology for immunology. Nat Rev Immunol. 2013;13:592\u2013605.","journal-title":"Nat Rev Immunol"},{"key":"12_CR23","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1160\/TH11-05-0336","volume":"106","author":"GS Getz","year":"2011","unstructured":"Getz GS, Vanderlaan PA, Reardon CA. Natural killer T cells in lipoprotein metabolism and atherosclerosis. Thromb Haemost. 2011;106:814\u20139.","journal-title":"Thromb Haemost"},{"key":"12_CR24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/ng1524","volume":"37","author":"X Wang","year":"2005","unstructured":"Wang X, Ria M, Kelmenson PM, Eriksson P, Higgins DC, Samnegard A, et al. Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat Genet. 2005;37:365\u201372.","journal-title":"Nat Genet"},{"key":"12_CR25","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nm1343","volume":"12","author":"H Ait-Oufella","year":"2006","unstructured":"Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, Zoll J, et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med. 2006;12:178\u201380.","journal-title":"Nat Med"},{"key":"12_CR26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1161\/CIRCRESAHA.109.210781","volume":"106","author":"KE Paulson","year":"2010","unstructured":"Paulson KE, Zhu SN, Chen M, Nurmohamed S, Jongstra-Bilen J, Cybulsky MI. Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis. Circ Res. 2010;106:383\u201390.","journal-title":"Circ Res"},{"key":"12_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri2675","volume":"10","author":"I Tabas","year":"2010","unstructured":"Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol. 2010;10:36\u201346.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"12_CR28","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/joim.12406","volume":"278","author":"GK Hansson","year":"2015","unstructured":"Hansson GK, Libby P, Tabas I. Inflammation and plaque vulnerability. J Intern Med. 2015;278(5):483\u201393.","journal-title":"J Intern Med"},{"key":"12_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/ni.2001","volume":"12","author":"GK Hansson","year":"2011","unstructured":"Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011;12:204\u201312.","journal-title":"Nat Immunol"},{"key":"12_CR30","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.106.676890","volume":"116","author":"I Tabas","year":"2007","unstructured":"Tabas I, Williams KJ, Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation. 2007;116:1832\u201344.","journal-title":"Circulation"},{"key":"12_CR31","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nature00804","volume":"417","author":"K Skalen","year":"2002","unstructured":"Skalen K, Gustafsson M, Rydberg EK, Hulten LM, Wiklund O, Innerarity TL, et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature. 2002;417:750\u20134.","journal-title":"Nature"},{"key":"12_CR32","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1161\/01.RES.0000210579.35304.d3","volume":"98","author":"E Cernuda-Morollon","year":"2006","unstructured":"Cernuda-Morollon E, Ridley AJ. Rho GTPases and leukocyte adhesion receptor expression and function in endothelial cells. Circ Res. 2006;98:757\u201367.","journal-title":"Circ Res"},{"key":"12_CR33","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1172\/JCI112200","volume":"76","author":"MP Bevilacqua","year":"1985","unstructured":"Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone Jr MA. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest. 1985;76:2003\u201311.","journal-title":"J Clin Invest"},{"key":"12_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.atherosclerosis.2016.01.002","volume":"246","author":"R Escate","year":"2016","unstructured":"Escate R, Padro T, Badimon L. LDL accelerates monocyte to macrophage differentiation: effects on adhesion and anoikis. Atherosclerosis. 2016;246:177\u201386.","journal-title":"Atherosclerosis"},{"key":"12_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1600-065X.2008.00706.x","volume":"226","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev. 2008;226:205\u201318.","journal-title":"Immunol Rev"},{"key":"12_CR36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nri2294","volume":"8","author":"CN Serhan","year":"2008","unstructured":"Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8:349\u201361.","journal-title":"Nat Rev Immunol"},{"key":"12_CR37","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/00041433-199410000-00003","volume":"5","author":"JH Campbell","year":"1994","unstructured":"Campbell JH, Campbell GR. The role of smooth muscle cells in atherosclerosis. Curr Opin Lipidol. 1994;5:323\u201330.","journal-title":"Curr Opin Lipidol"},{"key":"12_CR38","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/1358863X08094801","volume":"14","author":"E Adiguzel","year":"2009","unstructured":"Adiguzel E, Ahmad PJ, Franco C, Bendeck MP. Collagens in the progression and complications of atherosclerosis. Vasc Med. 2009;14:73\u201389.","journal-title":"Vasc Med"},{"key":"12_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1172\/JCI29950","volume":"117","author":"FK Swirski","year":"2007","unstructured":"Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, Weissleder R, et al. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest. 2007;117:195\u2013205.","journal-title":"J Clin Invest"},{"key":"12_CR40","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fimmu.2014.00514","volume":"5","author":"P Italiani","year":"2014","unstructured":"Italiani P, Boraschi D. From monocytes to M1\/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol. 2014;5:514.","journal-title":"Front Immunol"},{"key":"12_CR41","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1084\/jem.20060245","volume":"203","author":"J Jongstra-Bilen","year":"2006","unstructured":"Jongstra-Bilen J, Haidari M, Zhu SN, Chen M, Guha D, Cybulsky MI. Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. J Exp Med. 2006;203:2073\u201383.","journal-title":"J Exp Med"},{"key":"12_CR42","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1161\/CIRCULATIONAHA.108.807537","volume":"119","author":"EL Gautier","year":"2009","unstructured":"Gautier EL, Huby T, Saint-Charles F, Ouzilleau B, Pirault J, Deswaerte V, et al. Conventional dendritic cells at the crossroads between immunity and cholesterol homeostasis in atherosclerosis. Circulation. 2009;119:2367\u201375.","journal-title":"Circulation"},{"key":"12_CR43","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1172\/JCI44925","volume":"121","author":"C Weber","year":"2011","unstructured":"Weber C, M eiler S, Doring Y, Koch M, Drechsler M, Megens RT, et al. CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice. J Clin Invest. 2011;121:2898\u2013910.","journal-title":"J Clin Invest"},{"key":"12_CR44","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/labinvest.2010.94","volume":"90","author":"YV Bobryshev","year":"2010","unstructured":"Bobryshev YV. Dendritic cells and their role in atherogenesis. Lab Investig J Tech Methods Pathol. 2010;90:970\u201384.","journal-title":"Lab Investig J Tech Methods Pathol"},{"key":"12_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.clim.2009.05.006","volume":"134","author":"A Niessner","year":"2010","unstructured":"Niessner A, Weyand CM. Dendritic cells in atherosclerotic disease. Clin Immunol. 2010;134:25\u201332.","journal-title":"Clin Immunol"},{"key":"12_CR46","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.1021\/nn1023363","volume":"5","author":"B Van de Broek","year":"2011","unstructured":"Van de Broek B, Devoogdt N, D\u2019Hollander A, Gijs HL, Jans K, Lagae L, et al. Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy. ACS Nano. 2011;5:4319\u201328.","journal-title":"ACS Nano"},{"key":"12_CR47","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140:805\u201320.","journal-title":"Cell"},{"key":"12_CR48","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1073\/pnas.76.1.333","volume":"76","author":"JL Goldstein","year":"1979","unstructured":"Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A. 1979;76:333\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12_CR49","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.imbio.2012.02.015","volume":"217","author":"J Kzhyshkowska","year":"2012","unstructured":"Kzhyshkowska J, Neyen C, Gordon S. Role of macrophage scavenger receptors in atherosclerosis. Immunobiology. 2012;217:492\u2013502.","journal-title":"Immunobiology"},{"key":"12_CR50","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/nm.1994","volume":"15","author":"J Liu","year":"2009","unstructured":"Liu J, Divoux A, Sun J, Zhang J, Clement K, Glickman JN, et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med. 2009;15:940\u20135.","journal-title":"Nat Med"},{"key":"12_CR51","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1161\/CIRCRESAHA.107.160697","volume":"102","author":"A Zernecke","year":"2008","unstructured":"Zernecke A, Bot I, Djalali-Talab Y, Shagdarsuren E, Bidzhekov K, Meiler S, et al. Protective role of CXC receptor 4\/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res. 2008;102:209\u201317.","journal-title":"Circ Res"},{"key":"12_CR52","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1161\/ATVBAHA.110.221549","volume":"31","author":"MW Majesky","year":"2011","unstructured":"Majesky MW, Dong XR, Hoglund V, Mahoney Jr WM, Daum G. The adventitia: a dynamic interface containing resident progenitor cells. Arterioscler Thromb Vasc Biol. 2011;31:1530\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"12_CR53","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3389\/fphys.2014.00296","volume":"5","author":"M Akhavanpoor","year":"2014","unstructured":"Akhavanpoor M, Wangler S, Gleissner CA, Korosoglou G, Katus HA, Erbel C. Adventitial inflammation and its interaction with intimal atherosclerotic lesions. Front Physiol. 2014;5:296.","journal-title":"Front Physiol"},{"key":"12_CR54","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1161\/CIRCRESAHA.111.263186","volume":"110","author":"KA Campbell","year":"2012","unstructured":"Campbell KA, Lipinski MJ, Doran AC, Skaflen MD, Fuster V, McNamara CA. Lymphocytes and the adventitial immune response in atherosclerosis. Circ Res. 2012;110:889\u2013900.","journal-title":"Circ Res"},{"key":"12_CR55","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20080752","volume":"206","author":"R Grabner","year":"2009","unstructured":"Grabner R, Lotzer K, Dopping S, Hildner M, Radke D, Beer M, et al. Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE\u2212\/\u2212 mice. J Exp Med. 2009;206:233\u201348.","journal-title":"J Exp Med"},{"key":"12_CR56","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nri3520","volume":"13","author":"KJ Moore","year":"2013","unstructured":"Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol. 2013;13:709\u201321.","journal-title":"Nat Rev Immunol"},{"key":"12_CR57","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.4049\/jimmunol.157.9.4159","volume":"157","author":"P Saren","year":"1996","unstructured":"Saren P, Welgus HG, Kovanen PT. TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol. 1996;157:4159\u201365.","journal-title":"J Immunol"},{"key":"12_CR58","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1161\/CIRCULATIONAHA.111.046755","volume":"125","author":"Y Doring","year":"2012","unstructured":"Doring Y, Manthey HD, Drechsler M, Lievens D, Megens RT, Soehnlein O, et al. Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation. 2012;125:1673\u201383.","journal-title":"Circulation"},{"key":"12_CR59","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/ATVBAHA.112.301155","volume":"33","author":"JM van Gils","year":"2013","unstructured":"van Gils JM, Ramkhelawon B, Fernandes L, Stewart MC, Guo L, Seibert T, et al. Endothelial expression of guidance cues in vessel wall homeostasis dysregulation under proatherosclerotic conditions. Arterioscler Thromb Vasc Biol. 2013;33:911\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"12_CR60","doi-asserted-by":"publisher","first-page":"MR17","DOI":"10.1116\/1.2815690","volume":"2","author":"C Buzea","year":"2007","unstructured":"Buzea C, Pacheco II, Robbie K. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases. 2007;2:MR17\u201371.","journal-title":"Biointerphases"},{"key":"12_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcis.2012.11.061","volume":"395","author":"S Yan","year":"2013","unstructured":"Yan S, Gu W, Xu ZP. Re-considering how particle size and other properties of antigen-adjuvant complexes impact on the immune responses. J Colloid Interface Sci. 2013;395:1\u201310.","journal-title":"J Colloid Interface Sci"},{"key":"12_CR62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0005-2736(93)90115-G","volume":"1150","author":"TM Allen","year":"1993","unstructured":"Allen TM, Hansen CB, Guo LS. Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection. Biochim Biophys Acta. 1993;1150:9\u201316.","journal-title":"Biochim Biophys Acta"},{"key":"12_CR63","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.semcdb.2015.05.004","volume":"41","author":"M Haniffa","year":"2015","unstructured":"Haniffa M, Bigley V, Collin M. Human mononuclear phagocyte system reunited. Semin Cell Dev Biol. 2015;41:59\u201369.","journal-title":"Semin Cell Dev Biol"},{"key":"12_CR64","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jhep.2014.10.006","volume":"62","author":"O Strauss","year":"2015","unstructured":"Strauss O, Dunbar PR, Bartlett A, Phillips A. The immunophenotype of antigen presenting cells of the mononuclear phagocyte system in normal human liver\u2014a systematic review. J Hepatol. 2015;62:458\u201368.","journal-title":"J Hepatol"},{"key":"12_CR65","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1681\/ASN.2011070680","volume":"23","author":"PJ Nelson","year":"2012","unstructured":"Nelson PJ, Rees AJ, Griffin MD, Hughes J, Kurts C, Duffield J. The renal mononuclear phagocytic system. J Am Soc Nephrol. 2012;23:194\u2013203.","journal-title":"J Am Soc Nephrol"},{"key":"12_CR66","first-page":"435","volume":"6","author":"C Gottschalk","year":"2015","unstructured":"Gottschalk C, Kurts C. The debate about dendritic cells and macrophages in the kidney. Front Immunol. 2015;6:435.","journal-title":"Front Immunol"},{"key":"12_CR67","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2217\/nnm.11.19","volume":"6","author":"JV Jokerst","year":"2011","unstructured":"Jokerst JV, Lobovkina T, Zare RN, Gambhir SS. Nanoparticle PEGylation for imaging and therapy. Nanomedicine (London, England). 2011;6:715\u201328.","journal-title":"Nanomedicine (London, England)"},{"key":"12_CR68","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0021-9797(91)90043-8","volume":"142","author":"SI Jeon","year":"1991","unstructured":"Jeon SI, Lee JH, Andrade JD, De Gennes PG. Protein\u2014surface interactions in the presence of polyethylene oxide. J Colloid Interface Sci. 1991;142:149\u201358.","journal-title":"J Colloid Interface Sci"},{"key":"12_CR69","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1021\/nn506750r","volume":"9","author":"ME Lobatto","year":"2015","unstructured":"Lobatto ME, Calcagno C, Millon A, Senders ML, Fay F, Robson PM, et al. Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging. ACS Nano. 2015;9:1837\u201347.","journal-title":"ACS Nano"},{"key":"12_CR70","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jconrel.2008.03.019","volume":"128","author":"K Park","year":"2008","unstructured":"Park K, Hong HY, Moon HJ, Lee BH, Kim IS, Kwon IC, et al. A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides. J Control Release. 2008;128:217\u201323.","journal-title":"J Control Release"},{"key":"12_CR71","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1161\/01.ATV.0000235724.11299.76","volume":"26","author":"PM Winter","year":"2006","unstructured":"Winter PM, Neubauer AM, Caruthers SD, Harris TD, Robertson JD, Williams TA, et al. Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Arterioscler Thromb Vasc Biol. 2006;26:2103\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"12_CR72","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1161\/CIRCIMAGING.109.896654","volume":"3","author":"D Li","year":"2010","unstructured":"Li D, Patel AR, Klibanov AL, Kramer CM, Ruiz M, Kang BY, et al. Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT\/CT and magnetic resonance. Circ Cardiovasc Imaging. 2010;3:464\u201372.","journal-title":"Circ Cardiovasc Imaging"},{"key":"12_CR73","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1039\/c2cs15309b","volume":"41","author":"I Canton","year":"2012","unstructured":"Canton I, Battaglia G. Endocytosis at the nanoscale. Chem Soc Rev. 2012;41:2718\u201339.","journal-title":"Chem Soc Rev"},{"key":"12_CR74","doi-asserted-by":"publisher","first-page":"a016980","DOI":"10.1101\/cshperspect.a016980","volume":"5","author":"A Akinc","year":"2013","unstructured":"Akinc A, Battaglia G. Exploiting endocytosis for nanomedicines. Cold Spring Harb Perspect Biol. 2013;5:a016980.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"Suppl 1","key":"12_CR75","first-page":"51","volume":"9","author":"N Oh","year":"2014","unstructured":"Oh N, Park JH. Endocytosis and exocytosis of nanoparticles in mammalian cells. Int J Nanomedicine. 2014;9 Suppl 1:51\u201363.","journal-title":"Int J Nanomedicine"},{"key":"12_CR76","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S0962-8924(00)89101-1","volume":"5","author":"JA Swanson","year":"1995","unstructured":"Swanson JA, Watts C. Macropinocytosis. Trends Cell Biol. 1995;5:424\u20138.","journal-title":"Trends Cell Biol"},{"key":"12_CR77","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.addr.2007.06.008","volume":"59","author":"LM Bareford","year":"2007","unstructured":"Bareford LM, Swaan PW. Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev. 2007;59:748\u201358.","journal-title":"Adv Drug Deliv Rev"},{"key":"12_CR78","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nrd2591","volume":"9","author":"RA Petros","year":"2010","unstructured":"Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov. 2010;9:615\u201327.","journal-title":"Nat Rev Drug Discov"},{"key":"12_CR79","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/imr.12212","volume":"262","author":"SA Freeman","year":"2014","unstructured":"Freeman SA, Grinstein S. Phagocytosis: receptors, signal integration, and the cytoskeleton. Immunol Rev. 2014;262:193\u2013215.","journal-title":"Immunol Rev"},{"key":"12_CR80","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1146\/annurev.biochem.78.081307.110540","volume":"78","author":"GJ Doherty","year":"2009","unstructured":"Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annu Rev Biochem. 2009;78:857\u2013902.","journal-title":"Annu Rev Biochem"},{"key":"12_CR81","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/smll.200901158","volume":"6","author":"A Verma","year":"2010","unstructured":"Verma A, Stellacci F. Effect of surface properties on nanoparticle\u2013cell interactions. Small. 2010;6:12\u201321.","journal-title":"Small"},{"key":"12_CR82","doi-asserted-by":"publisher","first-page":"6867","DOI":"10.1016\/j.biomaterials.2010.05.027","volume":"31","author":"R Kedmi","year":"2010","unstructured":"Kedmi R, Ben-Arie N, Peer D. The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation. Biomaterials. 2010;31:6867\u201375.","journal-title":"Biomaterials"},{"key":"12_CR83","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<141::AID-IJC24>3.0.CO;2-0","volume":"83","author":"LA Rund","year":"1999","unstructured":"Rund LA, Cho BK, Manning TC, Holler PD, Roy EJ, Kranz DM. Bispecific agents target endogenous murine T cells against human tumor xenografts. Int J Cancer. 1999;83:141\u20139.","journal-title":"Int J Cancer"},{"key":"12_CR84","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jconrel.2012.11.007","volume":"165","author":"I Altintas","year":"2013","unstructured":"Altintas I, Heukers R, van der Meel R, Lacombe M, Amidi M, van Bergen En Henegouwen PM, et al. Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells. J Control Release. 2013;165:110\u20138.","journal-title":"J Control Release"},{"key":"12_CR85","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","volume":"82","author":"S Muyldermans","year":"2013","unstructured":"Muyldermans S. Nanobodies: natural single-domain antibodies. Annu Rev Biochem. 2013;82:775\u201397.","journal-title":"Annu Rev Biochem"},{"key":"12_CR86","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jconrel.2014.07.040","volume":"192","author":"LJ Cruz","year":"2014","unstructured":"Cruz LJ, Rosalia RA, Kleinovink JW, Rueda F, Lowik CW, Ossendorp F. Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative study. J Control Release. 2014;192:209\u201318.","journal-title":"J Control Release"},{"key":"12_CR87","doi-asserted-by":"publisher","first-page":"239sr1","DOI":"10.1126\/scitranslmed.3005101","volume":"6","author":"WJ Mulder","year":"2014","unstructured":"Mulder WJ, Jaffer FA, Fayad ZA, Nahrendorf M. Imaging and nanomedicine in inflammatory atherosclerosis. Sci Transl Med. 2014;6:239sr1.","journal-title":"Sci Transl Med"},{"key":"12_CR88","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3109\/10611860008996862","volume":"8","author":"N Jaulin","year":"2000","unstructured":"Jaulin N, Appel M, Passirani C, Barratt G, Labarre D. Reduction of the uptake by a macrophagic cell line of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate). J Drug Target. 2000;8:165\u201372.","journal-title":"J Drug Target"},{"key":"12_CR89","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1016\/j.biomaterials.2007.11.025","volume":"29","author":"JE Fuller","year":"2008","unstructured":"Fuller JE, Zugates GT, Ferreira LS, Ow HS, Nguyen NN, Wiesner UB, et al. Intracellular delivery of core-shell fluorescent silica nanoparticles. Biomaterials. 2008;29:1526\u201332.","journal-title":"Biomaterials"},{"key":"12_CR90","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nm1247","volume":"11","author":"M Stroh","year":"2005","unstructured":"Stroh M, Zimmer JP, Duda DG, Levchenko TS, Cohen KS, Brown EB, et al. Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo. Nat Med. 2005;11:678\u201382.","journal-title":"Nat Med"},{"key":"12_CR91","doi-asserted-by":"publisher","first-page":"20826","DOI":"10.1073\/pnas.1213291110","volume":"109","author":"TV Esipova","year":"2012","unstructured":"Esipova TV, Ye X, Collins JE, Sakadzic S, Mandeville ET, Murray CB, et al. Dendritic upconverting nanoparticles enable in vivo multiphoton microscopy with low-power continuous wave sources. Proc Natl Acad Sci U S A. 2012;109:20826\u201331.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12_CR92","doi-asserted-by":"publisher","first-page":"064005","DOI":"10.1117\/1.2822882","volume":"12","author":"RM Bateman","year":"2007","unstructured":"Bateman RM, Hodgson KC, Kohli K, Knight D, Walley KR. Endotoxemia increases the clearance of mPEGylated 5000-MW quantum dots as revealed by multiphoton microvascular imaging. J Biomed Opt. 2007;12:064005.","journal-title":"J Biomed Opt"},{"key":"12_CR93","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1039\/c2cs15337h","volume":"41","author":"M Colombo","year":"2012","unstructured":"Colombo M, Carregal-Romero S, Casula MF, Gutierrez L, Morales MP, Bohm IB, et al. Biological applications of magnetic nanoparticles. Chem Soc Rev. 2012;41:4306\u201334.","journal-title":"Chem Soc Rev"},{"key":"12_CR94","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1039\/b419004a","volume":"130","author":"I Chourpa","year":"2005","unstructured":"Chourpa I, Douziech-Eyrolles L, Ngaboni-Okassa L, Fouquenet JF, Cohen-Jonathan S, Souce M, et al. Molecular composition of iron oxide nanoparticles, precursors for magnetic drug targeting, as characterized by confocal Raman microspectroscopy. Analyst. 2005;130:1395\u2013403.","journal-title":"Analyst"},{"key":"12_CR95","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1016\/j.biomaterials.2004.10.012","volume":"26","author":"AK Gupta","year":"2005","unstructured":"Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005;26:3995\u20134021.","journal-title":"Biomaterials"},{"key":"12_CR96","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1021\/nl404816m","volume":"14","author":"MA Bruckman","year":"2014","unstructured":"Bruckman MA, Jiang K, Simpson EJ, Randolph LN, Luyt LG, Yu X, et al. Dual-modal magnetic resonance and fluorescence imaging of atherosclerotic plaques in vivo using VCAM-1 targeted tobacco mosaic virus. Nano Lett. 2014;14:1551\u20138.","journal-title":"Nano Lett"},{"key":"12_CR97","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nmat3780","volume":"13","author":"R Weissleder","year":"2014","unstructured":"Weissleder R, Nahrendorf M, Pittet MJ. Imaging macrophages with nanoparticles. Nat Mater. 2014;13:125\u201338.","journal-title":"Nat Mater"},{"key":"12_CR98","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/jmri.24200","volume":"39","author":"P Seyfer","year":"2014","unstructured":"Seyfer P, Pagenstecher A, Mandic R, Klose KJ, Heverhagen JT. Cancer and inflammation: differentiation by USPIO-enhanced MR imaging. J Magn Reson Imaging: JMRI. 2014;39:665\u201372.","journal-title":"J Magn Reson Imaging: JMRI"},{"key":"12_CR99","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1007\/s10439-011-0482-3","volume":"40","author":"R Wong","year":"2012","unstructured":"Wong R, Chen X, Wang Y, Hu X, Jin MM. Visualizing and quantifying acute inflammation using ICAM-1 specific nanoparticles and MRI quantitative susceptibility mapping. Ann Biomed Eng. 2012;40:1328\u201338.","journal-title":"Ann Biomed Eng"},{"key":"12_CR100","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s10554-010-9736-7","volume":"27","author":"S Metz","year":"2011","unstructured":"Metz S, Beer AJ, Settles M, Pelisek J, Botnar RM, Rummeny EJ, et al. Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability. Int J Cardiovasc Imaging. 2011;27:901\u201312.","journal-title":"Int J Cardiovasc Imaging"},{"key":"12_CR101","doi-asserted-by":"publisher","first-page":"W302","DOI":"10.2214\/AJR.14.12733","volume":"204","author":"A Neuwelt","year":"2015","unstructured":"Neuwelt A, Sidhu N, Hu CA, Mlady G, Eberhardt SC, Sillerud LO. Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation. AJR Am J Roentgenol. 2015;204:W302\u201313.","journal-title":"AJR Am J Roentgenol"},{"key":"12_CR102","first-page":"87","volume":"8","author":"S Lee","year":"2009","unstructured":"Lee S, Chen X. Dual-modality probes for in vivo molecular imaging. Mol Imaging. 2009;8:87\u2013100.","journal-title":"Mol Imaging"},{"key":"12_CR103","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11307-011-0528-9","volume":"14","author":"A Azhdarinia","year":"2012","unstructured":"Azhdarinia A, Ghosh P, Ghosh S, Wilganowski N, Sevick-Muraca EM. Dual-labeling strategies for nuclear and fluorescence molecular imaging: a review and analysis. Mol Imaging Biol. 2012;14:261\u201376.","journal-title":"Mol Imaging Biol"},{"key":"12_CR104","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1039\/b821903f","volume":"24","author":"LE Jennings","year":"2009","unstructured":"Jennings LE, Long NJ. \u2018Two is better than one\u2019\u2014probes for dual-modality molecular imaging. Chem Commun (Camb). 2009;24:3511\u201324.","journal-title":"Chem Commun (Camb)"},{"key":"12_CR105","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1039\/C2CS15261D","volume":"41","author":"DE Lee","year":"2012","unstructured":"Lee DE, Koo H, Sun IC, Ryu JH, Kim K, Kwon IC. Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem Soc Rev. 2012;41:2656\u201372.","journal-title":"Chem Soc Rev"},{"key":"12_CR106","doi-asserted-by":"publisher","first-page":"e14523","DOI":"10.1371\/journal.pone.0014523","volume":"6","author":"H Kosuge","year":"2011","unstructured":"Kosuge H, Sherlock SP, Kitagawa T, Terashima M, Barral JK, Nishimura DG, et al. FeCo\/graphite nanocrystals for multi-modality imaging of experimental vascular inflammation. PLoS One. 2011;6:e14523.","journal-title":"PLoS One"},{"key":"12_CR107","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nano.2008.12.002","volume":"5","author":"R Southworth","year":"2009","unstructured":"Southworth R, Kaneda M, Chen J, Zhang L, Zhang H, Yang X, et al. Renal vascular inflammation induced by Western diet in ApoE-null mice quantified by (19)F NMR of VCAM-1 targeted nanobeacons. Nanomedicine. 2009;5:359\u201367.","journal-title":"Nanomedicine"},{"key":"12_CR108","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1161\/CIRCRESAHA.111.300576","volume":"112","author":"MD Majmudar","year":"2013","unstructured":"Majmudar MD, Yoo J, Keliher EJ, Truelove JJ, Iwamoto Y, Sena B, et al. Polymeric nanoparticle PET\/MR imaging allows macrophage detection in atherosclerotic plaques. Circ Res. 2013;112:755\u201361.","journal-title":"Circ Res"},{"key":"12_CR109","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1023\/A:1016248701505","volume":"12","author":"K Kawabata","year":"1995","unstructured":"Kawabata K, Takakura Y, Hashida M. The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake. Pharm Res. 1995;12:825\u201330.","journal-title":"Pharm Res"},{"key":"12_CR110","first-page":"3","volume":"54","author":"JA Wolff","year":"2005","unstructured":"Wolff JA, Budker V. The mechanism of naked DNA uptake and expression. Adv Genet. 2005;54:3\u201320.","journal-title":"Adv Genet"},{"key":"12_CR111","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jconrel.2012.05.020","volume":"161","author":"D Vercauteren","year":"2012","unstructured":"Vercauteren D, Rejman J, Martens TF, Demeester J, De Smedt SC, Braeckmans K. On the cellular processing of non-viral nanomedicines for nucleic acid delivery: mechanisms and methods. J Control Release. 2012;161:566\u201381.","journal-title":"J Control Release"},{"key":"12_CR112","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2174\/156720111795256174","volume":"8","author":"M Elsabahy","year":"2011","unstructured":"Elsabahy M, Nazarali A, Foldvari M. Non-viral nucleic acid delivery: key challenges and future directions. Curr Drug Deliv. 2011;8:235\u201344.","journal-title":"Curr Drug Deliv"},{"key":"12_CR113","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/mt.2014.30","volume":"22","author":"Y Ding","year":"2014","unstructured":"Ding Y, Jiang Z, Saha K, Kim CS, Kim ST, Landis RF, et al. Gold nanoparticles for nucleic acid delivery. Mol Ther. 2014;22:1075\u201383.","journal-title":"Mol Ther"},{"key":"12_CR114","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1021\/ar3000162","volume":"45","author":"J Nguyen","year":"2012","unstructured":"Nguyen J, Szoka FC. Nucleic acid delivery: the missing pieces of the puzzle? Acc Chem Res. 2012;45:1153\u201362.","journal-title":"Acc Chem Res"},{"key":"12_CR115","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/nature07774","volume":"458","author":"M Aouadi","year":"2009","unstructured":"Aouadi M, Tesz GJ, Nicoloro SM, Wang M, Chouinard M, Soto E, et al. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature. 2009;458:1180\u20134.","journal-title":"Nature"},{"key":"12_CR116","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1126\/science.1149859","volume":"319","author":"D Peer","year":"2008","unstructured":"Peer D, Park EJ, Morishita Y, Carman CV, Shimaoka M. Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target. Science. 2008;319:627\u201330.","journal-title":"Science"},{"key":"12_CR117","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nbt.1989","volume":"29","author":"F Leuschner","year":"2011","unstructured":"Leuschner F, Dutta P, Gorbatov R, Novobrantseva TI, Donahoe JS, Courties G, et al. Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol. 2011;29:1005\u201310.","journal-title":"Nat Biotechnol"},{"key":"12_CR118","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1161\/CIRCRESAHA.113.302089","volume":"114","author":"X Sun","year":"2014","unstructured":"Sun X, He S, Wara AK, Icli B, Shvartz E, Tesmenitsky Y, et al. Systemic delivery of microRNA-181b inhibits nuclear factor-kappaB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice. Circ Res. 2014;114:32\u201340.","journal-title":"Circ Res"},{"key":"12_CR119","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1159\/000430303","volume":"36","author":"Y Yang","year":"2015","unstructured":"Yang Y, Yang L, Liang X, Zhu G. MicroRNA-155 Promotes Atherosclerosis Inflammation via Targeting SOCS1. Cell Physiol Biochem. 2015;36:1371\u201381.","journal-title":"Cell Physiol Biochem"},{"key":"12_CR120","doi-asserted-by":"publisher","first-page":"E1695","DOI":"10.1073\/pnas.1201516109","volume":"109","author":"IA Babar","year":"2012","unstructured":"Babar IA, Cheng CJ, Booth CJ, Liang X, Weidhaas JB, Saltzman WM, et al. Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc Natl Acad Sci U S A. 2012;109:E1695\u2013704.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12_CR121","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIRCRESAHA.117.305844","volume":"117","author":"K Li","year":"2015","unstructured":"Li K, Ching D, Luk FS, Raffai RL. Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-kappaB-driven inflammation and atherosclerosis. Circ Res. 2015;117:e1\u201311.","journal-title":"Circ Res"},{"key":"12_CR122","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1161\/CIRCULATIONAHA.112.000736","volume":"127","author":"Y Wei","year":"2013","unstructured":"Wei Y, Nazari-Jahantigh M, Chan L, Zhu M, Heyll K, Corbalan-Campos J, et al. The microRNA-342-5p fosters inflammatory macrophage activation through an Akt1- and microRNA-155-dependent pathway during atherosclerosis. Circulation. 2013;127:1609\u201319.","journal-title":"Circulation"},{"key":"12_CR123","doi-asserted-by":"publisher","first-page":"III27","DOI":"10.1161\/01.CIR.0000115644.35804.8B","volume":"109","author":"J Davignon","year":"2004","unstructured":"Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109:III27\u201332.","journal-title":"Circulation"},{"key":"12_CR124","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/circ.105.10.1158","volume":"105","author":"K Edfeldt","year":"2002","unstructured":"Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation. 2002;105:1158\u201361.","journal-title":"Circulation"},{"key":"12_CR125","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00441-008-0678-5","volume":"335","author":"AV Sima","year":"2009","unstructured":"Sima AV, Stancu CS, Simionescu M. Vascular endothelium in atherosclerosis. Cell Tissue Res. 2009;335:191\u2013203.","journal-title":"Cell Tissue Res"},{"key":"12_CR126","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jconrel.2013.12.029","volume":"176","author":"PS Kowalski","year":"2014","unstructured":"Kowalski PS, Zwiers PJ, Morselt HW, Kuldo JM, Leus NG, Ruiters MH, et al. Anti-VCAM-1 SAINT-O-Somes enable endothelial-specific delivery of siRNA and downregulation of inflammatory genes in activated endothelium in vivo. J Control Release. 2014;176:64\u201375.","journal-title":"J Control Release"},{"key":"12_CR127","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.gene.2015.04.014","volume":"565","author":"CF Chen","year":"2015","unstructured":"Chen CF, Huang J, Li H, Zhang C, Huang X, Tong G, et al. MicroRNA-221 regulates endothelial nitric oxide production and inflammatory response by targeting adiponectin receptor 1. Gene. 2015;565:246\u201351.","journal-title":"Gene"},{"key":"12_CR128","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/CIRCRESAHA.114.302213","volume":"114","author":"X Loyer","year":"2014","unstructured":"Loyer X, Potteaux S, Vion AC, Guerin CL, Boulkroun S, Rautou PE, et al. Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice. Circ Res. 2014;114:434\u201343.","journal-title":"Circ Res"},{"key":"12_CR129","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/cvr\/cvs094","volume":"95","author":"S Allahverdian","year":"2012","unstructured":"Allahverdian S, Pannu PS, Francis GA. Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation. Cardiovasc Res. 2012;95:165\u201372.","journal-title":"Cardiovasc Res"},{"key":"12_CR130","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1161\/CIRCRESAHA.115.304634","volume":"115","author":"S Feil","year":"2014","unstructured":"Feil S, Fehrenbacher B, Lukowski R, Essmann F, Schulze-Osthoff K, Schaller M, et al. Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis. Circ Res. 2014;115:662\u20137.","journal-title":"Circ Res"},{"key":"12_CR131","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejpb.2012.01.013","volume":"81","author":"D Kim","year":"2012","unstructured":"Kim D, Lee D, Jang YL, Chae SY, Choi D, Jeong JH, et al. Facial amphipathic deoxycholic acid-modified polyethyleneimine for efficient MMP-2 siRNA delivery in vascular smooth muscle cells. Eur J Pharm Biopharm. 2012;81:14\u201323.","journal-title":"Eur J Pharm Biopharm"},{"key":"12_CR132","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1172\/JCI63108","volume":"123","author":"AH Lichtman","year":"2013","unstructured":"Lichtman AH, Binder CJ, Tsimikas S, Witztum JL. Adaptive immunity in atherogenesis: new insights and therapeutic approaches. J Clin Invest. 2013;123:27\u201336.","journal-title":"J Clin Invest"},{"key":"12_CR133","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00281-009-0153-8","volume":"31","author":"RR Packard","year":"2009","unstructured":"Packard RR, Lichtman AH, Libby P. Innate and adaptive immunity in atherosclerosis. Semin Immunopathol. 2009;31:5\u201322.","journal-title":"Semin Immunopathol"},{"key":"12_CR134","doi-asserted-by":"publisher","first-page":"6211","DOI":"10.1016\/j.biomaterials.2012.04.060","volume":"33","author":"EA Scott","year":"2012","unstructured":"Scott EA, Stano A, Gillard M, Maio-Liu AC, Swartz MA, Hubbell JA. Dendritic cell activation and T cell priming with adjuvant- and antigen-loaded oxidation-sensitive polymersomes. Biomaterials. 2012;33:6211\u20139.","journal-title":"Biomaterials"},{"key":"12_CR135","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1016\/j.biomaterials.2013.02.024","volume":"34","author":"A Stano","year":"2013","unstructured":"Stano A, Scott EA, Dane KY, Swartz MA, Hubbell JA. Tunable T cell immunity towards a protein antigen using polymersomes vs. solid-core nanoparticles. Biomaterials. 2013;34:4339\u201346.","journal-title":"Biomaterials"},{"key":"12_CR136","doi-asserted-by":"publisher","first-page":"7850","DOI":"10.1021\/nn302122h","volume":"6","author":"AE Vasdekis","year":"2012","unstructured":"Vasdekis AE, Scott EA, O\u2019Neil CP, Psaltis D, Hubbell JA. Precision intracellular delivery based on optofluidic polymersome rupture. ACS Nano. 2012;6:7850\u20137.","journal-title":"ACS Nano"},{"key":"12_CR137","doi-asserted-by":"publisher","first-page":"11328","DOI":"10.1021\/la900649m","volume":"25","author":"S Cerritelli","year":"2009","unstructured":"Cerritelli S, O\u2019Neil CP, Velluto D, Fontana A, Adrian M, Dubochet J, et al. Aggregation behavior of poly(ethylene glycol-bl-propylene sulfide) di- and triblock copolymers in aqueous solution. Langmuir. 2009;25:11328\u201335.","journal-title":"Langmuir"},{"key":"12_CR138","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ejim.2003.08.010","volume":"14","author":"Z Levy","year":"2003","unstructured":"Levy Z, Rachmani R, Trestman S, Dvir A, Shaish A, Ravid M, et al. Low-dose interferon-alpha accelerates atherosclerosis in an LDL receptor-deficient mouse model. Eur J Int Med. 2003;14:479\u201383.","journal-title":"Eur J Int Med"},{"key":"12_CR139","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/79747","volume":"1","author":"M Cella","year":"2000","unstructured":"Cella M, Facchetti F, Lanzavecchia A, Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol. 2000;1:305\u201310.","journal-title":"Nat Immunol"},{"key":"12_CR140","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.chom.2012.04.017","volume":"11","author":"M Macal","year":"2012","unstructured":"Macal M, Lewis GM, Kunz S, Flavell R, Harker JA, Zuniga EI. Plasmacytoid dendritic cells are productively infected and activated through TLR-7 early after arenavirus infection. Cell Host Microbe. 2012;11:617\u201330.","journal-title":"Cell Host Microbe"},{"key":"12_CR141","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1084\/jem.194.6.863","volume":"194","author":"N Kadowaki","year":"2001","unstructured":"Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F, et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med. 2001;194:863\u20139.","journal-title":"J Exp Med"},{"key":"12_CR142","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.106.633263","volume":"114","author":"I Gotsman","year":"2006","unstructured":"Gotsman I, Grabie N, Gupta R, Dacosta R, MacConmara M, Lederer J, et al. Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. Circulation. 2006;114:2047\u201355.","journal-title":"Circulation"},{"key":"12_CR143","doi-asserted-by":"publisher","first-page":"5240","DOI":"10.1158\/0008-5472.CAN-12-2271","volume":"72","author":"C Conrad","year":"2012","unstructured":"Conrad C, Gregorio J, Wang YH, Ito T, Meller S, Hanabuchi S, et al. Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3(+) T-regulatory cells. Cancer Res. 2012;72:5240\u20139.","journal-title":"Cancer Res"},{"key":"12_CR144","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1161\/01.STR.0000034789.82859.A4","volume":"33","author":"C Espinola-Klein","year":"2002","unstructured":"Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Victor A, et al. Impact of infectious burden on progression of carotid atherosclerosis. Stroke J Cereb Circ. 2002;33:2581\u20136.","journal-title":"Stroke J Cereb Circ"},{"key":"12_CR145","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1161\/hc2601.091703","volume":"104","author":"HJ Rupprecht","year":"2001","unstructured":"Rupprecht HJ, Blankenberg S, Bickel C, Rippin G, Hafner G, Prellwitz W, et al. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation. 2001;104:25\u201331.","journal-title":"Circulation"},{"key":"12_CR146","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.atherosclerosis.2012.03.002","volume":"223","author":"RC Hechter","year":"2012","unstructured":"Hechter RC, Budoff M, Hodis HN, Rinaldo CR, Jenkins FJ, Jacobson LP, et al. Herpes simplex virus type 2 (HSV-2) as a coronary atherosclerosis risk factor in HIV-infected men: multicenter AIDS cohort study. Atherosclerosis. 2012;223:433\u20136.","journal-title":"Atherosclerosis"},{"key":"12_CR147","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cmet.2010.06.008","volume":"12","author":"P Goossens","year":"2010","unstructured":"Goossens P, Gijbels MJ, Zernecke A, Eijgelaar W, Vergouwe MN, van der Made I, et al. Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions. Cell Metab. 2010;12:142\u201353.","journal-title":"Cell Metab"},{"key":"12_CR148","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1161\/CIRCULATIONAHA.107.697789","volume":"116","author":"A Niessner","year":"2007","unstructured":"Niessner A, Shin MS, Pryshchep O, Goronzy JJ, Chaikof EL, Weyand CM. Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque. Circulation. 2007;116:2043\u201352.","journal-title":"Circulation"},{"key":"12_CR149","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/joim.12127","volume":"275","author":"OA Ovchinnikova","year":"2014","unstructured":"Ovchinnikova OA, Berge N, Kang C, Urien C, Ketelhuth DF, Pottier J, et al. Mycobacterium bovis BCG killed by extended freeze-drying induces an immunoregulatory profile and protects against atherosclerosis. J Intern Med. 2014;275:49\u201358.","journal-title":"J Intern Med"},{"key":"12_CR150","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00281-009-0151-x","volume":"31","author":"GK Hansson","year":"2009","unstructured":"Hansson GK, Nilsson J. Vaccination against atherosclerosis? Induction of atheroprotective immunity. Semin Immunopathol. 2009;31:95\u2013101.","journal-title":"Semin Immunopathol"},{"key":"12_CR151","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1161\/01.ATV.21.1.108","volume":"21","author":"X Zhou","year":"2001","unstructured":"Zhou X, Caligiuri G, Hamsten A, Lefvert AK, Hansson GK. LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler Thromb Vasc Biol. 2001;21:108\u201314.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"12_CR152","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1016\/j.vaccine.2008.04.065","volume":"26","author":"X Yuan","year":"2008","unstructured":"Yuan X, Yang X, Cai D, Mao D, Wu J, Zong L, et al. Intranasal immunization with chitosan\/pCETP nanoparticles inhibits atherosclerosis in a rabbit model of atherosclerosis. Vaccine. 2008;26:3727\u201334.","journal-title":"Vaccine"},{"key":"12_CR153","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.arcmed.2015.06.004","volume":"46","author":"V Garcia-Gonzalez","year":"2015","unstructured":"Garcia-Gonzalez V, Delgado-Coello B, Perez-Torres A, Mas-Oliva J. Reality of a vaccine in the prevention and treatment of atherosclerosis. Arch Med Res. 2015;46:427\u201337.","journal-title":"Arch Med Res"},{"key":"12_CR154","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jsb.2014.02.002","volume":"186","author":"V Garcia-Gonzalez","year":"2014","unstructured":"Garcia-Gonzalez V, Gutierrez-Quintanar N, Mendoza-Espinosa P, Brocos P, Pineiro A, Mas-Oliva J. Key structural arrangements at the C-terminus domain of CETP suggest a potential mechanism for lipid-transfer activity. J Struct Biol. 2014;186:19\u201327.","journal-title":"J Struct Biol"},{"key":"12_CR155","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1182\/blood-2008-04-149609","volume":"112","author":"A Shimabukuro-Vornhagen","year":"2008","unstructured":"Shimabukuro-Vornhagen A, Liebig T, von Bergwelt-Baildon M. Statins inhibit human APC function: implications for the treatment of GVHD. Blood. 2008;112:1544\u20135.","journal-title":"Blood"},{"key":"12_CR156","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1189\/jlb.0205064","volume":"79","author":"A Yilmaz","year":"2006","unstructured":"Yilmaz A, Reiss C, Weng A, Cicha I, Stumpf C, Steinkasserer A, et al. Differential effects of statins on relevant functions of human monocyte-derived dendritic cells. J Leukoc Biol. 2006;79:529\u201338.","journal-title":"J Leukoc Biol"},{"key":"12_CR157","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1038\/ncomms4065","volume":"5","author":"R Duivenvoorden","year":"2014","unstructured":"Duivenvoorden R, Tang J, Cormode DP, Mieszawska AJ, Izquierdo-Garcia D, Ozcan C, et al. A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation. Nat Commun. 2014;5:3065.","journal-title":"Nat Commun"},{"key":"12_CR158","doi-asserted-by":"crossref","unstructured":"Tang J, Lobatto ME, Hassing L, van der Staay S, van Rijs SM, Calcagno C, et al. Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation. Sci Adv. 2015;1.","DOI":"10.1126\/sciadv.1400223"},{"key":"12_CR159","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1161\/ATVBAHA.110.221499","volume":"31","author":"M Nahrendorf","year":"2011","unstructured":"Nahrendorf M, Keliher E, Marinelli B, Leuschner F, Robbins CS, Gerszten RE, et al. Detection of macrophages in aortic aneurysms by nanoparticle positron emission tomography-computed tomography. Arterioscler Thromb Vasc Biol. 2011;31:750\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"12_CR160","doi-asserted-by":"publisher","first-page":"9445","DOI":"10.1073\/pnas.1301929110","volume":"110","author":"S Marrache","year":"2013","unstructured":"Marrache S, Dhar S. Biodegradable synthetic high-density lipoprotein nanoparticles for atherosclerosis. Proc Natl Acad Sci U S A. 2013;110:9445\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12_CR161","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1021\/bc500517k","volume":"26","author":"BL Sanchez-Gaytan","year":"2015","unstructured":"Sanchez-Gaytan BL, Fay F, Lobatto ME, Tang J, Ouimet M, Kim Y, et al. HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophages. Bioconjug Chem. 2015;26:443\u201351.","journal-title":"Bioconjug Chem"},{"key":"12_CR162","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1021\/acs.molpharmaceut.5b00181","volume":"12","author":"B Oh","year":"2015","unstructured":"Oh B, Lee CH. Development of Man-rGO for targeted eradication of macrophage ablation. Mol Pharm. 2015;12:3226\u201336.","journal-title":"Mol Pharm"},{"key":"12_CR163","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1126\/science.aaa8064","volume":"349","author":"A Warnatsch","year":"2015","unstructured":"Warnatsch A, Ioannou M, Wang Q, Papayannopoulos V. Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science. 2015;349:316\u201320.","journal-title":"Science"},{"key":"12_CR164","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nnano.2014.17","volume":"9","author":"Z Wang","year":"2014","unstructured":"Wang Z, Li J, Cho J, Malik AB. Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils. Nat Nanotechnol. 2014;9:204\u201310.","journal-title":"Nat Nanotechnol"},{"key":"12_CR165","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1021\/mp100203a","volume":"8","author":"J Park","year":"2011","unstructured":"Park J, Gao W, Whiston R, Strom TB, Metcalfe S, Fahmy TM. Modulation of CD4+ T lymphocyte lineage outcomes with targeted, nanoparticle-mediated cytokine delivery. Mol Pharm. 2011;8:143\u201352.","journal-title":"Mol Pharm"},{"key":"12_CR166","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1182\/blood-2012-02-410936","volume":"120","author":"C Guillerey","year":"2012","unstructured":"Guillerey C, Mouries J, Polo G, Doyen N, Law HK, Chan S, et al. Pivotal role of plasmacytoid dendritic cells in inflammation and NK-cell responses after TLR9 triggering in mice. Blood. 2012;120:90\u20139.","journal-title":"Blood"},{"key":"12_CR167","first-page":"1165","volume":"118","author":"C Liu","year":"2008","unstructured":"Liu C, Lou Y, Lizee G, Qin H, Liu S, Rabinovich B, et al. Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice. J Clin Invest. 2008;118:1165\u201375.","journal-title":"J Clin Invest"},{"key":"12_CR168","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00441-010-1023-3","volume":"343","author":"L Van Kaer","year":"2011","unstructured":"Van Kaer L, Parekh VV, Wu L. Invariant natural killer T cells: bridging innate and adaptive immunity. Cell Tissue Res. 2011;343:43\u201355.","journal-title":"Cell Tissue Res"},{"key":"12_CR169","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nrmicro1657","volume":"5","author":"E Tupin","year":"2007","unstructured":"Tupin E, Kinjo Y, Kronenberg M. The unique role of natural killer T cells in the response to microorganisms. Nat Rev Microbiol. 2007;5:405\u201317.","journal-title":"Nat Rev Microbiol"},{"key":"12_CR170","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.4049\/jimmunol.178.5.2706","volume":"178","author":"NA Nagarajan","year":"2007","unstructured":"Nagarajan NA, Kronenberg M. Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J Immunol. 2007;178:2706\u201313.","journal-title":"J Immunol"},{"key":"12_CR171","doi-asserted-by":"publisher","first-page":"6401","DOI":"10.1021\/ac500719u","volume":"86","author":"G Stubiger","year":"2014","unstructured":"Stubiger G, Wuczkowski M, Bicker W, Belgacem O. Nanoparticle-based detection of oxidized phospholipids by MALDI mass spectrometry: nano-MALDI approach. Anal Chem. 2014;86:6401\u20139.","journal-title":"Anal Chem"},{"key":"12_CR172","doi-asserted-by":"publisher","first-page":"8003","DOI":"10.1039\/C5NR01050K","volume":"7","author":"AN Kharlamov","year":"2015","unstructured":"Kharlamov AN, Tyurnina AE, Veselova VS, Kovtun OP, Shur VY, Gabinsky JL. Silica-gold nanoparticles for atheroprotective management of plaques: results of the NANOM-FIM trial. Nanoscale. 2015;7:8003\u201315.","journal-title":"Nanoscale"},{"key":"12_CR173","doi-asserted-by":"publisher","first-page":"275ra20","DOI":"10.1126\/scitranslmed.aaa1065","volume":"7","author":"G Fredman","year":"2015","unstructured":"Fredman G, Kamaly N, Spolitu S, Milton J, Ghorpade D, Chiasson R, et al. Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice. Sci Transl Med. 2015;7:275ra20.","journal-title":"Sci Transl Med"}],"container-title":["Regenerative Engineering and Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40883-016-0012-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40883-016-0012-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40883-016-0012-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40883-016-0012-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T03:28:08Z","timestamp":1692242888000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40883-016-0012-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":173,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["12"],"URL":"https:\/\/doi.org\/10.1007\/s40883-016-0012-9","relation":{},"ISSN":["2364-4133","2364-4141"],"issn-type":[{"value":"2364-4133","type":"print"},{"value":"2364-4141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"20 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}